JPET Introducing ALZET?ew Model 2006 Pump

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by VANDENBELT, J. M.
Right arrow Articles by SIBERT, M.
Right arrow Search for Related Content
PubMed
Right arrow Articles by VANDENBELT, J. M.
Right arrow Articles by SIBERT, M.
Journal of Pharmacology And Experimental Therapeutics, Vol. 80, Issue 1, 31-38, 1944
Copyright © 1944 by American Society for Pharmacology and Experimental Therapeutics


METHEMOGLOBINEMIA AFTER ADMINISTRATION OF p-AMINOACETOPHENONE AND p-AMINOPROPIOPHENONE

J. M. VANDENBELT 1, CARL PFEIFFER 1, MARGARET KAISER 1, and MARGARET SIBERT 1

1 From the Research and Biological Laboratories, Parke, Davis & Co., Detroit, Mich.

The compounds, p-aminoacetophenone and p-aminopropiophenone, whether given orally or intravenously, are highly active in forming methemoglobin. The latter is the more active, being as active as p-dinitrobenzene, but differing in that its effect is less rapid and more prolonged. Death occurs at 95% methemoglobinemia and recovery may occur with 87% methemoglobinemia. Due to the desirable chemical and pharmacological properties of p-aminopropiophenone this compound may prove of value for the experimental production of methemoglobinemia and anoxia.

Submitted on August 19, 1943







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1944 by the American Society for Pharmacology and Experimental Therapeutics.